2024-07-24T09:12:46-05:00 2023-12-31 410746749 CLIFTONLARSONALLEN LLP 220 S 6TH STREET SUITE 300 MINNEAPOLIS MN 55402 990 2023-01-01 412122813 VITREORETINAL SURGERY FOUNDATION VITR 9522593466 3601 WEST 76TH STREET 300 EDINA MN 55435 HERBERT CANTRILL PRESIDENT 9522593466 2024-07-23 1 HERBERT CANTRILL 999009999 0 HEIDI TATRO P01591796 6123764500 2024-07-23 2 AAL1 IAL1 2023 2023-04-26 12:10:37Z HERBERT CANTRILL 3601 WEST 76TH STREET 300 EDINA MN 55435 234372 0 X VRSFOUNDATION.US X 2003 MN FURTHERING EDUCATION RELATING TO RETINAL MACULAR DISEASES AND ADVANCING CLINICAL RESEARCH. 9 9 0 9 0 0 128420 176476 38275 44275 6358 13621 0 0 173053 234372 96488 102019 0 0 0 0 0 0 0 48687 55191 145175 157210 27878 77162 835474 969388 64600 70925 770874 898463 X THE VITREORETINAL SURGERY FOUNDATION STRIVES TO PROMOTE EDUCATION AND RESEARCH RELATED TO RETINAL AND MACULAR DISEASES. WE SUPPORT RESEARCH BY FUNDING AWARDS FOR YOUNG INVESTIGATORS WITH A POTENTIAL FOR A CAREER DEVOTED TO RETINAL DISEASE AND RESEARCH. WE PROMOTE PROFESSIONAL EDUCATION BY SPONSORING COURSES DESIGNED FOR MEDICAL AND EYE CARE PROFESSIONALS. WE PROMOTE COMMUNITY OUTREACH EDUCATION BY RAISING AWARENESS OF RETINAL DISEASES, TREATMENT OPTIONS AND AVAILABLE RESOURCES. 0 0 40183 0 44275 THE VRS FOUNDATION SPONSORS THE ANNUAL RETINAL UPDATE CONTINUING EDUCATION CONFERENCE. THIS HAS BEEN THE PRIMARY EDUCATIONAL ACTIVITY OF THE VRSF AND HAS OCCURRED ANNUALLY FOR THE PAST 27 YEARS. THE TARGET AUDIENCE IS PRACTICING OPHTHALMOLOGISTS AND OPTOMETRISTS IN THE UPPER MIDWEST. PRESENTATIONS ARE GIVEN BY VRS PHYSICIANS, AS WELL AS AN INVITED NATIONAL RECOGNIZED SPEAKER. THIS CONFERENCE IS ACCREDITED BY THE MINNESOTA MEDICAL ASSOCIATION FOR 4 AMA PRA CATEGORY 1 CREDITS. THE OPHTHALMIC BUSINESS COMMUNITY HAS FINANCIALLY SUPPORTED THE CONFERENCE AND EXHIBITS THEIR LATEST INNOVATIONS. IT IS THE ONLY CONFERENCE SPECIFICALLY ADDRESSING DISEASES OF THE RETINA AND MACULA IN OUR REGION EACH YEAR. IN 2023, THERE WERE 142 ATTENDEES AND 12 EXHIBITORS AT THE CONFERENCE.IN ADDITION, THE VRS FOUNDATION HOSTS A RESIDENT/FELLOW CASE REVIEW CONFERENCE THE EVENING BEFORE THE RETINAL UPDATE COURSE. RESIDENTS AND FELLOWS FROM VRS, UNIVERSITY OF MINNESOTA AND MAYO CLINIC PRESENT CHALLENGING CASES TO RCM, U OF MN AND MAYO CLINIC STAFF PHYSICIANS AS WELL AS OUR INVITED NATIONAL SPEAKER. IN 2023, THERE WERE 35 ATTENDEES TO LEARN ABOUT 10 DIFFERENT CASES PRESENTED. 1250 1250 0 VRSF HAS SPONSORED THE PRIMARY RETINAL DETACHMENT OUTCOMES (PRO) STUDY. THIS RESEARCH PROJECT WAS BEGUN IN 2016 UNDER THE DIRECTION OF DR EDWIN RYAN, ITS PRINCIPAL INVESTIGATOR. IT HAS BEEN FUNDED BY A GRANT FROM THE ALLINA FOUNDATION, MINNEAPOLIS MN, TO THE VRSF. THE PRO STUDY COMPILED A LARGE, COMPREHENSIVE OBSERVATIONAL DATASET FROM PATIENTS WHO UNDERWENT REPAIR OF RETINAL DETACHMENT IN 2015 IN SIX STUDY CENTERS ACROSS THE COUNTRY. 61 VITREORETINAL SURGEONS PARTICIPATED IN THIS STUDY. NEARLY 3,000 CASES OF PRIMARY RETINAL DETACHMENT WERE ENTERED IN THE STUDY DATABASE. THE DATASET HAS NOW BEEN ANALYZED TO DETERMINE PRE-OPERATIVE, INTRA-OPERATIVE AND POST-OPERATIVE CHARACTERISTICS WHICH IMPACT THE OUTCOME OF PRIMARY RETINAL DETACHMENT SURGERY. THE RESULTS OF THE PRO STUDY HAVE BEEN WIDELY DISSEMINATED THROUGHOUT THE OPHTHALMIC COMMUNITY, AND WILL STRONGLY INFLUENCE THE MANAGEMENT OF RETINAL DETACHMENT FOR YEARS TO COME. THE PRO STUDY HAS SO FAR RESULTED IN 9 PRESENTATIONS AT NATIONAL AND INTERNATIONAL SYMPOSIA, AND 17 PUBLICATIONS IN PEER-REVIEWED JOURNALS. 100769 100769 0 SINCE THE FOUNDING OF THE VITREORETINAL SURGERY FOUNDATION (VRSF) 2005, WE HAVE MAINTAINED A ROBUST RESEARCH PROGRAM. THE GOAL OF THE RESEARCH PROGRAM HAS BEEN TO SUPPORT YOUNG INVESTIGATORS AND ENCOURAGE THEM TO PURSUE A CAREER FOCUSING ON DISEASES OF THE RETINA. OUR RESEARCH PROGRAM IS OPEN TO MEDICAL STUDENTS, RESIDENTS AND FELLOWS AT OPHTHALMOLOGY TRAINING PROGRAMS, AND FULLTIME RESEARCH TRAINEES AT ACADEMIC CENTERS. WE ARE CURRENTLY WORKING WITH 31 PRACTICE BASED AND UNIVERSITY AFFILIATED PROGRAMS ACROSS THE COUNTRY.WE OFFER TWO TYPES OF RESEARCH GRANTS. OUR RESEARCH AWARD IS DESIGNED FOR OPHTHALMOLOGY RESIDENTS AND FELLOWS WHO WANT TO PURSUE A RESEARCH PROJECT DURING THEIR CLINICAL TRAINING. THE AWARD CONSISTS OF A RESEARCH STIPEND OF $2,000 TOGETHER WITH AN ADDITIONAL $1,000 FOR RESEARCH RELATED EXPENSES AND $1,000 FOR TRAVEL EXPENSES TO PRESENT RESEARCH RESULTS AT A NATIONAL SYMPOSIUM. OUR RESEARCH FELLOWSHIP IS DESIGNED FOR SOMEONE INVOLVED IN FULLTIME RESEARCH AT AN ACADEMIC INSTITUTION PURSUING AN ADVANCED DEGREE, SUCH AS A PHD OR MD/PHD. THE FELLOWSHIP HAS A STIPEND OF $10,000 AND AN ADDITIONAL $1,000 FOR TRAVEL EXPENSES TO PRESENT RESEARCH RESULTS AT A NATIONAL SYMPOSIUM.EACH YEAR BEGINNING IN JULY WE SOLICIT APPLICATIONS FROM OUR 31 AFFILIATED TRAINING PROGRAMS. APPLICATIONS ARE REVIEWED BY OUR BOARD OF DIRECTORS CONSISTING OF MEMBERS OF OUR PROFESSIONAL PRACTICE, RETINA CONSULTANTS OF MINNESOTA PLLC, AS WELL AS REPRESENTATIVES FROM THE UNIVERSITY OF MINNESOTA AND THE MAYO CLINIC. THE APPLICATION PROCESS IS COMPETITIVE, WITH APPROXIMATELY HALF OF THE APPLICATIONS SELECTED FOR AN AWARD OR FELLOWSHIP. IN 2023, THERE WERE 65 APPLICATIONS, WITH 30 RESEARCH AWARDS GIVEN, AND 3 FELLOWSHIPS AWARDED.THE SUCCESS OF OUR RESEARCH PROGRAM CAN BE MEASURED BY THE NUMBER OF PRESENTATIONS OF RESEARCH RESULTS AT NATIONAL MEETINGS AND PUBLICATION OF RESEARCH MANUSCRIPTS BY PEER REVIEWED JOURNALS. RESEARCH RESULTS ARE FREQUENTLY CITED IN ACADEMIC AND PROFESSIONAL PUBLICATIONS. RESULTS OF PRESENTATIONS ARE SOMETIMES PICKED UP BY LOCAL OR NATIONAL MEDIA. PUBLISHED MANUSCRIPTS ARE AVAILABLE TO THE ACADEMIC AND RESEARCH COMMUNITY THROUGH THE PUBMED SEARCH ENGINE, AND MOST JOURNAL ARTICLES ARE AVAILABLE TO MEMBERS OF THE OPHTHALMOLOGY PROFESSION THROUGH OPEN SOURCE JOURNAL ACCESS. OVER THE LAST 5 YEARS THERE HAS BEEN 120 PRESENTATIONS AND 88 PUBLICATIONS. 142202 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 9 9 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 MN X GRETCHEN POFFENBERGER 9522593466 3601 W 76TH STREET SUITE 300 EDINA MN 55435 X HERBERT CANTRILL MD PRESIDENT 3.00 X X 0 0 0 PETER TANG MD PHD SECRETARY/TREASURER 1.00 X X 0 0 0 JOHN DAVIES MD DIRECTOR 1.00 X 0 0 0 TIMOTHY OLSEN MD DIRECTOR 1.00 X 0 0 0 CHRISTOPHER HWANG MN PHD DIRECTOR 1.00 X 0 0 0 HEIDI WILSON ESQ DIRECTOR 1.00 X 0 0 0 KAREN ARMBRUST MD PHD DIRECTOR 1.00 X 0 0 0 PETER BELIN MD DIRECTOR 1.00 X 0 0 0 GEOFFREY EMERSON MD PHD DIRECTOR 1.00 X 0 0 0 0 0 0 0 0 0 0 0 176476 176476 CONFERENCE REVENUE 900099 44275 44275 44275 13621 13621 234372 44275 0 13621 91285 91285 10734 10734 5460 5460 165 165 2288 2288 41731 37873 3858 2600 2600 CME SPONSORSHIP 2310 2310 MISCELLANEOUS 637 637 157210 142202 15008 0 538168 268793 342917 2310 6060 7800 2600 7800 5200 287196 346418 835474 969388 40000 46000 24600 24925 64600 70925 X 770874 898463 770874 898463 835474 969388 77162 50427 0 X 1 X 0 0 0 X 199382 186590 182499 128420 176476 873367 199382 186590 182499 128420 176476 873367 681989 191378 1540 2139 3519 6358 13621 27177 900544 194601 0.21250 0.26090 X OUR FOUNDATION ACCEPTS DONATIONS FROM OUR PROFESSIONAL COLLEAGUES, FROM THE FAMILIES OF GRATEFUL PATIENTS, AND FROM THE GENERAL PUBLIC. IN ADDITION, WE SOLICIT SUPPORT FROM THE OPHTHALMIC BUSINESS COMMUNITY FOR OUR EDUCATIONAL ACTIVITIES. FINALLY, THE PHYSICIANS OF VITREORETINAL SURGERY, AND THE MEMBERS OF OUR BOARD OF DIRECTORS HAVE BEEN STRONG FINANCIAL SUPPORTERS OF OUR FOUNDATION. MOST OF THE DONATIONS TO OUR FOUNDATION HAVE BEEN RELATIVELY SMALL AMOUNTS OF MONEY FROM THE FAMILIES OF GRATEFUL PATIENTS. WE HAVE, HOWEVER, RECEIVED MAJOR RECURRENT ANNUAL DONATIONS FROM THE HELEN LINDSAY FAMILY FOUNDATION, WHICH FAR EXCEED THE CONTRIBUTIONS FROM OUR OTHER DONORS. HELEN LINDSAY WAS A FORMER PATIENT OF OURS, AND HER FAMILY HAS SUPPORTED OUR FOUNDATION BECAUSE OF HER LOSS OF VISION FROM MACULAR DEGENERATION. ALTHOUGH WE ARE GRATEFUL FOR THEIR GENEROUS SUPPORT, THE HELEN LINDSAY FOUNDATION IN NO WAY INFLUENCES, OR CONTROLS OUR FOUNDATION. DONATIONS FROM THE HELEN LINDSAY FOUNDATION HAVE BEEN UNSOLICITED AND THEY HAVE PLACED NO RESTRICTIONS ON THE USE OF THE DONATED FUNDS. CONSEQUENTLY, WE FEEL THAT THEIR FINANCIAL SUPPORT IS ENTIRELY CONSISTENT WITH THE MISSION OF OUR FOUNDATION.IN ADDITION TO THE SUPPORT RECEIVED FROM THE HELEN LINDSAY FOUNDATION, THE ORGANIZATION HAS RECEIVED CONTRIBUTIONS FROM NUMEROUS OTHER INDIVIDUAL DONORS RANGING FROM 21 TO 85 DONORS IN EACH YEAR SINCE 2019.BECAUSE OF THE DISPARITY BETWEEN THE DONATION FROM THE HELEN LINDSAY FOUNDATION AND OUR OTHER DONATIONS WE HAVE FAILED THE PUBLIC SUPPORT TEST (IRS FORM 990) BEGINNING IN 2019. WE CONTINUE TO QUALIFY AS A PUBLIC CHARITY USING THE FACTS AND CIRCUMSTANCES TEST. PART OF THAT TEST IS TO MAINTAIN "A CONTINUOUS AND BONA FIDE PROGRAM" TO ATTRACT OTHER SUPPORT. AS PART OF THIS EFFORT THE BOARD OF DIRECTORS HAVE CONTACTED VARIOUS PRIVATE FOUNDATIONS LOCATED MOSTLY IN MINNESOTA TO SOLICIT SUPPORT FOR OUR FOUNDATION. A SEARCH OF PRIVATE FOUNDATIONS IN MINNESOTA (HTTP://MCF.ORG/MEMBERS#FAMILY) RESULTED IN 14 POSSIBLE FOUNDATIONS THAT APPEARED TO SUPPORT MEDICAL RESEARCH BASED ON INFORMATION FROM THEIR WEBSITESA LETTER AND A PACKET OF INFORMATION INCLUDING A DETAILED DESCRIPTION OF OUR RESEARCH PROGRAM WAS SENT TO THE DIRECTORS OF THESE FOUNDATIONS. THE RESPONSE SO FAR HAS NOT RESULTED IN ADDITIONAL DONATIONS TO OUR FOUNDATION.IN 2022 WE BEGAN WORK WITH A WEBSITE DEVELOPER TO CREATE OUR OWN WEBSITE SEPARATE FROM THE RETINA CONSULTANTS OF MINNESOTA WEBSITE. THE WEBSITE IS NOW ACTIVE WITH THE DOMAIN NAME VRSFOUNDATION.US. THE WEBSITE FEATURES OUR THREE GOALS: RESEARCH, EDUCATION AND COMMUNITY OUTREACH. THE WEBSITE CONTAINS OUR MISSION STATEMENT, THE HISTORY OF THE FOUNDATION AND BIO SKETCHES OF OUR BOARD OF DIRECTORS. THE RESEARCH SECTION LISTS OUR CURRENT RESEARCH PROJECTS AND A LIST OF PRESENTATIONS AND PUBLICATIONS FROM THE PREVIOUS YEAR. RESEARCH APPLICANTS CAN BE DOWNLOAD AND COMPLETED ONLINE. THE EDUCATION SECTION HIGHLIGHTS OUR RETINA UPDATE MEETING AND ALLOWS FOR ONLINE REGISTRATION. FINALLY, THE COMMUNITY OUTREACH SECTION HAS INFORMATION FOR PATIENTS AND THE GENERAL PUBLIC ABOUT RETINAL DISEASE, TREATMENT OPTIONS, AND VISUAL REHABILITATION. THERE ARE LINKS TO OTHER WEBSITES FOR ADDITIONAL INFORMATION ON LOW VISION AIDS, REHABILITATIONS SERVICES, AND PREVENTION OF RETINAL DISEASE. ONLINE DONATIONS TO THE FOUNDATION CAN BE DONE THROUGH THE WEBSITE. WE HAVE ALSO INITIATED A MARKETING PLAN TO RAISE AWARENESS OF OUR FOUNDATION THROUGHOUT OUR CLINICS AND THE OPHTHALMIC COMMUNITY. THIS INVOLVES PROMINENTLY DISPLAYING OUR FOUNDATION BROCHURE IN THE WAITING ROOM OF ALL OUR OFFICES. WE HAVE DISPLAYED INFORMATION ABOUT OUR FOUNDATION AT OUR ANNUAL RETINAL UPDATE MEETING. WE HOPE THESE EFFORTS WILL INCREASE THE NUMBER OF DONATIONS TO OUR FOUNDATION, BUT MAY NOT QUALIFY US UNDER THE PUBLIC SUPPORT TEST. NEVERTHELESS, WE FEEL THAT ALL OF OUR EFFORTS ARE SUFFICIENT FOR THE FACTS AND CIRCUMSTANCES TEST. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 7800 2600 5200 5200 X PART X, LINE 2: THE FOUNDATION IS A NONPROFIT CORPORATION AND HAS BEEN RECOGNIZED AS TAX-EXEMPT PURSUANT TO SECTION 501(C) (3) OF THE INTERNAL REVENUE CODE. THE FOUNDATION'S INCOME TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL, STATE, AND LOCAL AUTHORITIES. THE FOUNDATION IS NOT AWARE OF ANY ACTIVITIES THAT WOULD JEOPARDIZE ITS TAX-EXEMPT STATUS, AND IS NOT AWARE OF ANY ACTIVITIES THAT ARE SUBJECT TO TAX ON UNRELATED BUSINESS INCOME, EXCISE, OR OTHER TAXES. THE FOUNDATION FOLLOWS THE INCOME TAX STANDARD REGARDING THE RECOGNITION AND MEASUREMENT OF UNCERTAIN TAX PROVISIONS. THE APPLICATION OF THE ACCOUNTING STANDARDS REGARDING UNCERTAIN TAX PROVISIONS HAS NO IMPACT ON THE FOUNDATION'S FINANCIAL STATEMENTS. 1 DUKE UNIVERSITY 2138 CAMPUS DR DURHAM NC 27708 562070036 501(C)(3) 0 22677 N/A N/A RESEARCH/FELLOWSHIP AWARD STATE OF IOWA UNIVERSITY 2433 UNION DR AMES IA 50011 426004224 501(C)(3) 0 10000 N/A N/A RESEARCH/FELLOWSHIP AWARD STANFORD OFFICE OF RESEARCH ADMINISTRATION PO BOX 884253 LOS ANGELES CA 900884253 941156365 501(C)(3) 0 15000 N/A N/A RESEARCH/FELLOWSHIP AWARD 3 0 EXPENSE REIMBURSEMENTS 10 10734 PART I, LINE 2: THE BOARD REVIEWS ALL APPLICATIONS AND DETERMINES WHICH APPLICATIONS WARRANT FUNDING. FUNDS ARE RESTRICTED TO THE SPECIFIC PROJECT OF THE AWARD. THE BOARD REQUIRES WRITTEN PROGRESS REPORTS AND A FINANCIAL REPORT FROM THE RECIPIENT AND SPONSORING INSTITUTION AND UNUSED FUNDS ARE TO BE RETURNED. THE AWARDS DO NOT COVER INDIRECT COSTS. FORM 990, PART VI, SECTION A, LINE 1A THE BOARD OF DIRECTORS MAY BY ACTION OF A MAJORITY OF THE BOARD DESIGNATE TWO OR MORE MEMBERS AS AN EXECUTIVE COMMITTEE WHICH SHALL HAVE AND EXERCISE THE AUTHORITY OF TE BOARD IN MANAGEMENT OF THE CORPORTATION. THE EXECUTIVE COMMITTEE SHALL BE SUBJECT TO CONTROL AND DIRECTION OF THE BOARD. THE BOARD OF DIRECTORS MAY ALSO APPOINT SUCH OTHER COMMITTEES AS IT DEEMS PROPER. FORM 990, PART VI, SECTION B, LINE 11B THE BOARD MEMBERS WERE PROVIDED AN ELECTRONIC COPY OF THE FORM 990 FOR REVIEW AND DISCUSSION. THE BOARD APPROVED THE FORM 990 ELECTRONICALLY AND RATIFIED THE APPROVAL AT THE NEXT REGULARLY SCHEDULED BOARD MEETING. FORM 990, PART VI, SECTION B, LINE 12C EACH DIRECTOR, PRINCIPAL OFFICER AND MEMBER OF A COMMITTEE WITH BOARD DELEGATED POWERS ANNUALLY COMPLETES AND SIGNS A CONFLICT OF INTEREST STATEMENT. DIRECTORS, OFFICERS AND MANAGEMENT STAFF ARE PROHIBITED FROM ENGAGING IN ACTIVITIES THAT CONSTITUTE ACTUAL OR POTENTIAL CONFLICTS OF INTEREST OBJECTIONABLE TO THE CORPORATION. WHENEVER A DIRECTOR, OFFICER OR MANAGEMENT STAFF PERSON HAS REASON TO BELIEVE THAT HE OR SHE MAY HAVE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, THEY PROMPTLY DISCLOSE THE POTENTIAL CONFLICT TO THE EXECUTIVE DIRECTOR OR THE PRESIDENT. THE MATTER IS THEN PRESENTED TO THE BOARD AND ANY APPROPRIATE COMMITTEES. THE INTERESTED PERSON IS GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, THEY LEAVE THE BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE INDIVIDUAL WITH THE CONFLICT MAY NOT VOTE ON THE MATTER AND IS NOT COUNTED FOR DETERMINING THE PRESENCE OF A QUORUM. IN ADDRESSING THE CONFLICT OF INTEREST, THE COMMITTEE/BOARD CHAIR CAN APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES AND DETERMINE WHETHER THE CORPORATION COULD OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. IF A MORE ADVANTAGEOUS ARRANGEMENT IS NOT REASONABLY ATTAINABLE, THE BOARD OR COMMITTEE DETERMINES BY MAJORITY VOTE OF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN THE CORPORATION'S BEST INTEREST. IF THE BOARD OR A COMMITTEE HAS REASON TO BELIEVE THAT A MEMBER HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT INFORMS THE MEMBER OF THE BASIS FOR SUCH BELIEF AND AFFORDS THE MEMBER AN OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. IF, AFTER HEARING THE MEMBER'S RESPONSE AND MAKING FURTHER INVESTIGATION AS MAY BE WARRANTED, THE BOARD OR COMMITTEE DETERMINES THAT THE MEMBER HAS IN FACT FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT TAKES APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION. THE FAILURE OF A DIRECTOR, OFFICER OR MANAGEMENT STAFF MEMBER TO ACT IN ACCORDANCE WITH THE CONFLICT OF INTEREST POLICY MAY RESULT IN REMOVAL OF SUCH PERSON AND THE VOIDING OF RELATED ACTIONS TAKEN BY THE CORPORATION, INCLUDING TRANSACTIONS AND CONTRACTS TO WHICH THE CORPORATION IS A PARTY. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST.